High Viral Specific Antibody Convalescent Plasma Effectively Neutralizes SARS-CoV-2 Variants of Concern

Maggie Li, Evan J. Beck, Oliver Laeyendecker, Yolanda Eby, Aaron AR Tobian, Patrizio Caturegli, Camille Wouters, Gregory R. Chiklis, William Block, Robert McKie, Michael Joyner, Timothy D. Wiltshire, Allan B. Dietz, Thomas J. Gniadek, Arell Shapiro, Anusha Yarava, Karen Lane, Daniel Hanley, Evan M. Bloch, Shmuel Shoham, Edward R. Cachay, Barry R. Meisenberg, Moises A. Huaman, Yuriko Fukuta, Bela Patel, Sonya L. Heath, Adam C. Levine, James H. Paxton, Shweta Anjan, Jonathan M. Gerber, Kelly A. Gebo, Arturo Casadevall, Andrew Pekosz, David J. Sullivan, the CSSC group
doi: https://doi.org/10.1101/2022.03.01.22271662

Article Information

doi 
https://doi.org/10.1101/2022.03.01.22271662
History 
  • March 2, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

  1. Maggie Li1,
  2. Evan J. Beck2,
  3. Oliver Laeyendecker2,
  4. Yolanda Eby3,
  5. Aaron AR Tobian3,
  6. Patrizio Caturegli3,
  7. Camille Wouters1,
  8. Gregory R. Chiklis5,
  9. William Block6,
  10. Robert McKie7,
  11. Michael Joyner8,
  12. Timothy D. Wiltshire9,
  13. Allan B. Dietz9,
  14. Thomas J. Gniadek10,
  15. Arell Shapiro11,
  16. Anusha Yarava12,
  17. Karen Lane12,
  18. Daniel Hanley12,
  19. Evan M. Bloch3,
  20. Shmuel Shoham4,
  21. Edward R. Cachay13,
  22. Barry R. Meisenberg14,
  23. Moises A. Huaman15,
  24. Yuriko Fukuta16,
  25. Bela Patel17,
  26. Sonya L. Heath18,
  27. Adam C. Levine19,
  28. James H. Paxton20,
  29. Shweta Anjan21,
  30. Jonathan M. Gerber22,
  31. Kelly A. Gebo4,
  32. Arturo Casadevall1,
  33. Andrew Pekosz1,
  34. David J. Sullivan1,*,
  35. the CSSC group
  1. 1Johns Hopkins Bloomberg School of Public Health, Department of Molecular Microbiology and Immunology, Baltimore, MD
  2. 2Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH
  3. 3Johns Hopkins University School of Medicine, Department of Pathology, Baltimore, MD
  4. 4Johns Hopkins University School of Medicine, Department of Medicine, Division of Infectious Diseases, Baltimore, MD
  5. 5MRN Diagnostics, LLC Franklin, MA
  6. 6Blood Centers of America, West Warwick, RI
  7. 7Innovative Transfusion Medicine, Coral Springs, FL
  8. 8Departments of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN
  9. 9Department of Laboratory Medicine and Pathology, Division of Transfusion Medicine, Mayo Clinic, Rochester, MN
  10. 10Department of Pathology, Northshore University Health System, Evanston, IL
  11. 11Pathology, Hoag Hospital Newport Beach, CA
  12. 12Johns Hopkins University School of Medicine Department of Neurology, Brain Injury Outcomes Division, Baltimore, MD
  13. 13Department of Medicine, Division of Infectious Diseases, University of California, San Diego, San Diego, CA
  14. 14Luminis Health, Annapolis, MD
  15. 15Department of Medicine, Division of Infectious Diseases, University of Cincinnati, Cincinnati, OH
  16. 16Department of Medicine, Section of Infectious Diseases, Baylor College of Medicine, Houston, TX
  17. 17Department of Medicine, Divisions of Pulmonary and Critical Care Medicine, University of Texas Health Science Center, Houston, TX
  18. 18Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL
  19. 19Department of Emergency Medicine, Rhode Island Hospital/Brown University, Providence, RI
  20. 20Department of Emergency Medicine, Wayne State University, Detroit, MI
  21. 21Department of Medicine, Division of Infectious Diseases, University of Miami, Miller School of Medicine, Miami, FL
  22. 22Department of Medicine, Division of Hematology and Oncology, University of Massachusetts Chan Medical School, Worcester, MA
  1. ↵*Corresponding author: David Sullivan, Rm W4606, 615 N. Wolfe St, Baltimore, MD 21205, dsulliv7{at}jhmi.edu, telephone-410 502 2522 fax-410 955 0105
Back to top
Posted March 02, 2022.
Download PDF
Data/Code
Email
High Viral Specific Antibody Convalescent Plasma Effectively Neutralizes SARS-CoV-2 Variants of Concern
Maggie Li, Evan J. Beck, Oliver Laeyendecker, Yolanda Eby, Aaron AR Tobian, Patrizio Caturegli, Camille Wouters, Gregory R. Chiklis, William Block, Robert McKie, Michael Joyner, Timothy D. Wiltshire, Allan B. Dietz, Thomas J. Gniadek, Arell Shapiro, Anusha Yarava, Karen Lane, Daniel Hanley, Evan M. Bloch, Shmuel Shoham, Edward R. Cachay, Barry R. Meisenberg, Moises A. Huaman, Yuriko Fukuta, Bela Patel, Sonya L. Heath, Adam C. Levine, James H. Paxton, Shweta Anjan, Jonathan M. Gerber, Kelly A. Gebo, Arturo Casadevall, Andrew Pekosz, David J. Sullivan, the CSSC group
medRxiv 2022.03.01.22271662; doi: https://doi.org/10.1101/2022.03.01.22271662
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area